U.S. markets closed
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • Dow 30

    31,496.30
    +572.16 (+1.85%)
     
  • Nasdaq

    12,920.15
    +196.68 (+1.55%)
     
  • Russell 2000

    2,192.21
    +45.29 (+2.11%)
     
  • Crude Oil

    66.28
    +2.45 (+3.84%)
     
  • Gold

    1,698.20
    -2.50 (-0.15%)
     
  • Silver

    25.30
    -0.17 (-0.65%)
     
  • EUR/USD

    1.1916
    -0.0063 (-0.52%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • GBP/USD

    1.3834
    -0.0060 (-0.43%)
     
  • USD/JPY

    108.3600
    +0.3840 (+0.36%)
     
  • BTC-USD

    50,804.88
    +2,093.14 (+4.30%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Global Breast Cancer Diagnostic Testing Device Pipeline Assessment Report 2020 Featuring 186 Companies

Research and Markets
·5 min read

Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

"Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020". Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Scope

  • Extensive coverage of the Breast Cancer Diagnostic Tests under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Breast Cancer Overview

3 Products under Development
3.1 Breast Cancer - Pipeline Products by Stage of Development
3.2 Breast Cancer - Pipeline Products by Territory
3.3 Breast Cancer - Pipeline Products by Regulatory Path
3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
3.5 Breast Cancer - Ongoing Clinical Trials

4 Breast Cancer - Pipeline Products under Development by Companies
4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
4.2 Breast Cancer - Pipeline Products by Stage of Development

5 Breast Cancer Companies and Product Overview

6 Breast Cancer- Recent Developments

7 Appendix

Companies Mentioned

  • A&G Pharmaceutical Inc

  • Abviva Inc (Inactive)

  • Accelerated Medical Diagnostics LLC

  • Acobiom

  • Affichem SA

  • AIT Austrian Institute of Technology GmbH

  • Albert Ludwigs University of Freiburg

  • Alere Inc

  • Allarity Therapeutics A/S

  • Almac Diagnostic Services Ltd

  • Amarantus Bioscience Holdings Inc

  • AngioGenex Inc

  • Anixa Diagnostics Corporation

  • Armune BioScience Inc

  • Arno Therapeutics Inc

  • Assurance Biosciences, Inc. (Inactive)

  • Atossa Therapeutics Inc

  • Aurelium BioPharma Inc.

  • Autoimmune Technologies LLC

  • Avant Diagnostics Inc

  • Ayanda Biosystems SA (Inactive)

  • BARD1 Life Sciences Ltd

  • Baylor College of Medicine

  • BCAL Diagnostics Pty Limited

  • Becton Dickinson and Co

  • Biocrates Life Sciences AG

  • BioDesign Institute at Arizona State University

  • Biodesix Inc

  • BioGenex Laboratories Inc

  • Biolidics Ltd

  • BioMarCare Technologies Ltd

  • BioMark Diagnostics Inc

  • BioMarker Strategies LLC

  • bioMerieux SA

  • Biomoda Inc

  • Biosceptre International Ltd

  • BioSystems International

  • Caprion Biosciences Inc

  • Caris Life Sciences Inc

  • Celcuity Inc

  • Cellanyx Diagnostics, Inc.

  • CellXplore, Inc.

  • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco

  • Cepheid Inc

  • Ceres Nanosciences Inc

  • Cernostics Inc

  • China Sky One Medical Inc

  • Chronix Biomedical Inc

  • City of Hope

  • Clarient Inc

  • Cleveland Diagnostics Inc.

  • CompanDX Ltd

  • Courtagen Life Sciences Inc

  • Daan Gene Co Ltd

  • Dana-Farber Cancer Institute Inc

  • Dartmouth College

  • Dublin City University

  • Entopsis LLC

  • Eurobio Scientific SA

  • Exact Sciences Corp

  • Exosome Diagnostics Inc

  • Exosomics Siena SpA

  • Fahy Gurteen UK Ltd

  • Fina Biotech SL

  • Fluxion Biosciences Inc

  • Fournira Optime Diagnostics

  • French National Institute of Health and Medical Research

  • Genome Diagnostics Pvt Ltd

  • GenomicTree Co Ltd

  • Genoptix Inc

  • George Washington University

  • German Cancer Research Center

  • Ghent University

  • GlyCa BioSciences Inc

  • GlycoZym USA Inc

  • Guardant Health Inc

  • H. Lee Moffitt Cancer Center & Research Institute Inc

  • Hai Kang Life Corp Ltd

  • Health Discovery Corp

  • HealthTell Inc

  • Hebrew University of Jerusalem

  • Heragen Inc

  • Hitachi Chemical Diagnostics Inc

  • Houston Methodist Hospital

  • Ikonisys Inc

  • Immunovia AB

  • Inanovate Inc

  • Insight Genetics Inc

  • Inspirata Inc

  • Institute of Cancer Research

  • Institute of Molecular and Translational Medicine

  • IPDx Immunoprofiling Diagnostics GmbH

  • IRIS International Inc

  • Johns Hopkins University

  • Jonakee Cancer Research, Inc.

  • Kalgene Pharmaceuticals Inc

  • Leica Biosystems Nussloch GmbH

  • Liv Diagnostics AB

  • Louisville Bioscience Inc (Inactive)

  • MabCure Inc

  • Matrix-Bio Inc

  • MDNA Life Sciences Inc

  • MDxHealth SA

  • MEDITE Cancer Diagnostics Inc

  • MedMira Inc

  • MedPacto Inc

  • Metabolomic Technologies Inc

  • MetaStat Inc

  • Milagen Inc

  • Morphotek Inc

  • MW Diagnostics Ltd

  • Nanostics Inc

  • NanoString Technologies Inc

  • New York University

  • Newcastle University

  • Nonagen Bioscience Corp

  • Novel Bio-spectrum Technologies Inc (Inactive)

  • Nuclea Biotechnologies Inc. (Inactive)

  • Nuvera Biosciences Inc

  • Olink Proteomics AB

  • Olympia Diagnostics Inc

  • Oncimmune (USA) LLC

  • OncoCyte Corp

  • Onconome, Inc. (Inactive)

  • OncoStem Diagnostics Pvt. Ltd

  • OncoVista Innovative Therapies Inc

  • Oregon Health & Science University

  • OSLER Diagnostics Ltd

  • OTraces Inc

  • Peri Rx Inc

  • Power3 Medical Products, Inc.

  • Precision Biologics Inc

  • Prelude Corp

  • PreMD Inc (Inactive)

  • Princeton University

  • Proplex Technologies Llc

  • Protagen AG

  • Proteome Sciences Plc

  • Proteomika (Inactive)

  • Purdue University

  • Rna Diagnostics Inc

  • Roche Diagnostics Corp

  • Roche Diagnostics International Ltd

  • Rosetta Genomics Ltd

  • RWTH Aachen University

  • Savicell Diagnostic Ltd.

  • Selventa Inc

  • Sengenics Corp Pte Ltd

  • Siemens Healthineers AG

  • SomaLogic Inc

  • Soricimed Biopharma Inc

  • Syantra Inc

  • Target Discovery Inc

  • Taxor Diagnostics, LLC

  • TechnoGenesys, Inc.

  • The University of Nottingham

  • Treos Bio Inc

  • Trinity College Dublin

  • Universal Diagnostics SL

  • University of Alberta

  • University of Bergen

  • University of Bonn

  • University of California San Diego

  • University of Colorado

  • University of Hong Kong

  • University of Kansas

  • University of Lyon

  • University of Minnesota

  • University of Missouri

  • University of Nebraska

  • University of Oxford

  • University of Pittsburgh

  • University of South Carolina

  • University of South Florida

  • University of Toledo

  • University of Turku

  • University of Wisconsin Madison

  • US Biomarkers Inc

  • Vala Sciences Inc

  • Vermillion Inc

  • Viomics Inc.

  • Vitruvian Biomedical Inc

  • VolitionRX Ltd

  • Washington University in St Louis

  • XEPTAGEN SpA

  • Zetiq Technologies Ltd

For more information about this report visit https://www.researchandmarkets.com/r/amo3q4

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900